Skip to main content

Clinical Trial Results

Search

Dr. Kevin Alexander and Dr. C. Michael Gibson discuss datapresented at ACC 2025: Dr. Kevin Alexander, Acoramidis Improves Serum TTR Levels in Patients with Wild-Type or Variant Transthyretin Amyloid Cardiomyopathy sponsored byBridgeBio Pharma, Inc.

Disclosures: Sponsored by BridgeBio Pharma, Inc.